AXQ Capital’s Olema Pharmaceuticals OLMA Stock Holding History

AXQ Capital’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,633	Closed	-$218K	–	1248
2026 Q1	$218K	Sell	14,633 -6,690	-31%	-$149K	0.03%	712
2025 Q4	$533K	Buy	+21,323	New	+$379K	0.12%	287

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

AXQ Capital's OLMA Position: Q2 2026 in Review

AXQ Capital sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 14,633 shares — an estimated $218K sold.

AXQ Capital first reported a position in OLMA in Q4 2025 and held it in 2 quarters. The position peaked at $533K in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

AXQ Capital reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 14,633 Olema Pharmaceuticals shares in Q2 2026, an estimated $218K.
AXQ Capital first reported a position in Olema Pharmaceuticals in Q4 2025 and held it in 2 quarters.
AXQ Capital's Olema Pharmaceuticals position peaked at $533K in Q4 2025.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.